Clinical Trials List
Protocol NumberMOST 110-2314-B-182A-062 -
Not yet recruiting
2021-12-13 - 2023-07-31
Phase II
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Mengting Peng Division of Hematology & Oncology
- 謝憬儀 Division of Radiology
- Pao-Hsien Chu Division of Cardiovascular Diseases
- Gigin Lin Division of Radiology
- Wen-Cheng Chang Division of Hematology & Oncology
- 陳東藝 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
0 participants
